
Recently, the Swiss Agency for Therapeutic Products (Swissmedic) officially announced that the second module of the medical device database Swissdamed, namely "Device Registration", will release its first version (voluntary registration) in 2025, which is expected to accelerate market supervision and information transparency.
Swissdamed is a new database developed by Swissmedic. Its core function is to serve as a public platform for the registration and management of economic operators and medical devices (including In vitro Diagnostic Medical Devices, IVDs) in the Swiss market, and it functions in a similar vein to the European Union’s Eudamed database. The database will integrate, process, and disclose information about medical devices and relevant enterprises (e.g., manufacturers), enabling the public and healthcare professionals to access such information more conveniently and significantly enhancing market transparency.
- **August 6, 2024**: The first module "Actors (Economic Operators Registration)" was officially launched, allowing economic operators to complete registration online immediately. (Manufacturers not based in Switzerland are not required to complete the relevant registration and filing procedures on their own; this will be handled by their Swiss Authorized Representative (CH-REP).)
- **From 2025 onwards**: The second module "Devices (Medical Device Registration)" will be launched in multiple phases. After the initial release, "regulated devices" (i.e., devices compliant with the Medical Device Regulation (MDR) and In vitro Diagnostic Regulation (IVDR)) can be registered, and subsequent updates will continuously improve the functionality of this module.
Special Reminder: From July 1, 2026, if reports of serious incidents, field safety corrective actions, or relevant trends are involved, the corresponding devices must be registered immediately.
4. Improve post-market surveillance procedures to ensure prompt reporting of adverse events when they occur.